Literature DB >> 15933587

Fluorescein angiographic features of asymptomatic eyes in central serous chorioretinopathy.

Dhiren Bujarborua1, Samrat Chatterjee, Amit Choudhury, Geetanjali Bori, Ajit K Sarma.   

Abstract

PURPOSE: Analysis of the fundus and fluorescein angiography (FA) features of the asymptomatic eyes in patients of central serous chorioretinopathy (CSC) at initial visit and estimation of the overall magnitude of bilateral pathology.
METHODS: Retrospective observational case series that reviewed the medical records and FA features of 229 consecutive patients between January 1999 and December 2001.
RESULTS: Seventy-three (31.88%) patients had symptoms in one eye but signs in both the eyes, of which 70 were selected. Bilateral symptomatic CSC was seen in 29 (12.66%). Thus, overall bilateral involvement was found in 102 (44.54%) patients. FA features of asymptomatic eyes were pigment epithelial detachment (32.85%), fluorescein leak (31.42%), window defect (31.42%), depigmented patches (14.29%), drusen-like deposits (12.85%), pigment clumps (4.29%), retinal pigment epithelial atrophy (4.28%), subretinal precipitate (2.85%), and sensory retinal detachment (5.71%). Forty-three (61.43%) had evidence of chronic subclinical CSC, whereas 27(38.57%) had features of clinically healed CSC. CSC developed in the asymptomatic eyes within 3 to 12 months in four of the 24 followed-up patients.
CONCLUSION: Considerable number of asymptomatic eyes had features suggestive of healed or chronic subclinical CSC. These eyes are at risk for CSC caused by occurrence of active leak(s) from the same or new site(s).

Entities:  

Mesh:

Year:  2005        PMID: 15933587     DOI: 10.1097/00006982-200506000-00005

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  14 in total

1.  [Central serous chorioretinopathy (CSC)].

Authors:  H Baraki; N Feltgen; J Roider; H Hoerauf; C Klatt
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

2.  Morphological changes in the retinal pigment epithelium on spectral-domain OCT in the unaffected eyes with idiopathic central serous chorioretinopathy.

Authors:  Pawan Gupta; Vishali Gupta; M R Dogra; Ramandeep Singh; Amod Gupta
Journal:  Int Ophthalmol       Date:  2009-01-30       Impact factor: 2.031

3.  Central serous chorioretinopathy associated with rowatinex usage.

Authors:  İlknur Akyol-Salman; Deniz Leçe-Sertöz; Uğur Mumcu; Orhan Ateş; Orhan Baykal
Journal:  Eurasian J Med       Date:  2009-12

4.  [Spectral domain OCT in central serous chorioretinopathy: description of retinal changes].

Authors:  V Valet; C P Lohmann; M Maier
Journal:  Ophthalmologe       Date:  2012-09       Impact factor: 1.059

5.  [Selective retina therapy in central serous chorioretinopathy with detachment of the pigmentary epithelium].

Authors:  C Klatt; H Elsner; E Pörksen; R Brinkmann; A Bunse; R Birngruber; J Roider
Journal:  Ophthalmologe       Date:  2006-10       Impact factor: 1.059

6.  Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up.

Authors:  J Fernando Arevalo; Juan V Espinoza
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-03-30       Impact factor: 3.117

Review 7.  [Statement and recommendation of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the German Retina Society (RG) on central serous chorioretinopathy : Situation January 2018].

Authors: 
Journal:  Ophthalmologe       Date:  2018-05       Impact factor: 1.059

8.  Risk factors of persistent subretinal fluid after half-dose photodynamic therapy for treatment-naïve central serous chorioretinopathy.

Authors:  Mengyang Li; Jinfeng Qu; Zhiqiao Liang; Jiyang Tang; Jie Hu; Yuou Yao; Enzhong Jin; Xiaoxin Li; Mingwei Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-13       Impact factor: 3.117

Review 9.  Vision disorders and phosphodiesterase type 5 inhibitors: a review of the evidence to date.

Authors:  Alan M Laties
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

10.  Fundus autofluorescence in central serous chorioretinopathy: association with spectral-domain optical coherence tomography and fluorescein angiography.

Authors:  Peng Zhang; Hai-Yan Wang; Zi-Feng Zhang; Dong-Jie Sun; Jin-Ting Zhu; Juan Li; Yu-Sheng Wang
Journal:  Int J Ophthalmol       Date:  2015-10-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.